Vendor-CRO-CMO Oversight in the (Biopharma) and Device Industry
View: 282
Website https://www.compliance4all.com/control/w_product/~product_id=502215LIVE?channel=ourglocal_Dec_2018_S |
Edit Freely
Category Manufacturing, Pharmacovigilance, Compliance
Deadline: December 03, 2018 | Date: December 05, 2018
Venue/Country: Online, U.S.A
Updated: 2018-10-08 14:40:14 (GMT+9)
Call For Papers - CFP
Overview:This webinar is specifically designed for sponsoring biopharma and device companies who are outsourcing.It will help you get to grips with effective Vendors (including CRO,CMO, and other vendors) management used in the biopharma and device industries and your responsibilities as the sponsor.Areas Covered in the Session:Setting up vendor oversightInspector expectationsSelection of CROs to meet oversight requirementsEnsuring clarity of roles and responsibilitiesRFI and RFPContractual consideration for oversightThe oversight/quality planWho Will Benefit:RegulatoryManufacturingPharmacovigilanceComplianceAuditQualitySpeaker Profile:Dr. Laura Brown , PhD, MBA, Diploma Clinical Sciences, is an independent QA and training consultant in the pharmaceutical industry. She is a managing director with LB Training and Development Ltd., course director for the M.Sc. in Clinical Research, School of Pharmacy at the University of Cardiff, and course director for M.Sc. Regulatory Affairs, TOPRA.Event Fee: One Dial-in One Attendee Price: US$150.00Contact Detail:Compliance4All DBA NetZealous,Phone: +1-800-447-9407Email: supportcompliance4All.com
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.